The methylerythritol phosphate biosynthetic pathway, found in most Bacteria, some parasitic protists, and plant chloroplasts, converts D-glyceraldehyde phosphate and pyruvate to isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), where it intersects with the mevalonate pathway found in some Bacteria, Archaea, and Eukarya, including the cytosol of plants. 4-phosphate (MEP), the first pathway-specific intermediate in the pathway, is converted to IPP and DMAPP by the consecutive action of the IspD-H proteins. We synthesized five D-MEP analoguesD-erythritol-4-phosphate (EP), D-3-methylthrietol-4-phosphate (MTP), D-3-ethylerythritol-4-phosphate (EEP), D-1-amino-3-methylerythritol-4-phosphate (NMEP), and D-3-methylerythritol-4-thiolophosphate (MESP)and studied their ability to function as alternative substrates for the reactions catalyzed by the IspDF fusion and IspE proteins from Agrobacterium tumefaciens, which covert MEP to the corresponding eight-membered cyclic diphosphate. All of the analogues, except MTP, and their products were substrates for the three consecutive enzymes.
■ INTRODUCTION
The isoprenoid biosynthetic pathway produces over 60 000 small-molecule metabolites that perform numerous essential functions in all forms of life. 1 A few examples include electron transfer (ubiquinones), cellular membranes (sterols and hopanes), hormones (sterols, sesquiterpenes, diterpenes), pheromones (monoterpenes), photosynthesis (carotenoids and chlorophylls), and signal transduction (isoprenylated proteins). Isoprenoid molecules are synthesized from (R)-mevalonate (MVA) 2 or D-methylerythritol phosphate (MEP) 3 by two fundamentally different pathways. The MVA pathway provides isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) for isoprenoid biosynthesis in most Eukarya, including all mammals and the cytosol and mitochondria in plants, Archaea, and a few Bacteria. IPP and DMAPP are synthesized from MEP in most Bacteria and Apicomplexa, a group of parasitic protists. MEP is synthesized in two steps from pyruvate and Dglyceraldehyde phosphate via D-deoxyxylulose phosphate catalyzed by deoxyxylulose phosphate synthase (DXS) and deoxyxylulose keto-reductase (DXR or IspC), respectively. 3 MEP is converted to cyclic methylerythritol diphosphate (cMEDP) in three steps catalyzed by diphosphocytidylmethylerythritol (CDP-ME) synthase (IspD), diphosphocytidylmethylerythrityl phosphate (CDP-MEP) synthase (IspE), and cyclomethylerythrityl diphosphate (cMEDP) synthase (IspF). Subsequently, the cyclic diphosphate is opened reductively by hydroxydimethylallyl diphosphate (HDMAPP) synthase (IspG), and the hydroxyl group is removed by a second reduction by IspH to give a mixture of IPP and DMAPP. 3 The steps between MEP and IPP/DMAPP and the genes encoding the biosynthetic enzymes are shown in Scheme 1.
The ispD, ispE, and ispF genes encode monofunctional enzymes in most MEP-dependent organisms. However, there are several reports of fused ispD and ispF that encode bifunctional IspDF proteins in bacteria, including several genera of α-proteobacteria belonging to the order Rhizobiales. 4 The IspDF protein catalyzes the first and last steps in the conversion of MEP to cMEDP, and the missing ispE activity can be provided in vivo with an enzyme from the same or different organisms. Time course studies with IspDF and IspE from Agrobacterium tumefacians indicate that the enzymes in combination efficiently convert MEP to cMEDP without any evidence for substrate channeling between the individual active sites in the protein complex. 5 Since the MEP pathway is orthogonal to the MVA pathway, it is an attractive target for development of small-molecule EEP was prepared by a similar set of reactions. Treatment of ketone 1 with ethylmagnesium bromide proceeded with highly stereoselective axial-face addition to the carbonyl group. Previously, an "axial"/"equatorial" stereoselectivity of 20:1 was seen for the related addition of methylmagnesium bromide.
14 Desilylation with Bu 4 NF gave diol 6. The diol was lithiated with n-butyllithium and phosphorylated regioselectively at the primary hydroxyl group with freshly prepared dibenzyl chlorophosphate. Catalytic hydrogenolysis of the dibenzyl phosphate and benzylidene ring gave EEP.
NMEP was synthesized from (Z)-4-(tert-butyldimethylsilanyloxy)-3-methyl-but-2-en-1-ol (8) 16 (Scheme 3). Our original strategy involved phosphorylation of 8 using the benzyl phosphite-iodine procedure, 17 removal of the TBDMS group, and introduction of the amino group by a Mitsunobu displacement 18 with phthalimide, followed by hydrolysis of the imide. However, our attempts to hydrolyze the phthalimide group prior to a Sharpless dihydroxylation 19 failed, presumably because of the reactivity of the phosphate triester. Alcohol 8 was then protected as a THP ether; the TBDMS protecting group was removed; and nitrogen was introduced at C1 by a Mitsunobu displacement. 17 The phthalimide moiety was 
Scheme 2. Synthesis of EP and EEP
The Journal of Organic Chemistry removed with hydrazine, and the resulting amine was protected as a Boc amide. The THP blocking group was removed, and alcohol 14 was phosphorylated using benzyl phosphiteiodine. 17 A Sharpless dihydroxylation 19 gave 16 as a 12:1 mixture of 2R,3S and 2S,3R enantiomers, as judged by chiral HPLC. NMEP was obtained after removing the benzyl and Boc protecting groups.
The synthesis of MESP is outlined in Scheme 4. Ester 17 16 was asymmetrically dihydroxylated as described for 15.
19 Diol 18 was first protected as an orthoester. Although the reaction proceeded in high yield as judged from an NMR spectrum of the crude product, the orthoester was unstable on a silica column and was isolated in 51% yield. Reduction of the methyl ester with LiBH 4 proceeded in excellent yield (NMR), but again the resulting alcohol was unstable on silica and was obtained in 61% yield after purification. To improve yields, we omitted purification steps for reactions 2 and 3, and pure tosylated orthoester (steps 2−4) was obtained in an overall 89% yield. The orthoester protecting group was removed in two steps by a mild treatment with aq. HCl to give a formate ester, followed by hydrolysis with ammonia in CH 3 OH to give diol tosylate 22. Treatment of 22 with tBuOK and removal of the silyl blocking group gave epoxide 24, which was opened with inorganic thiophosphate to give MESP. An NMR analysis of the C1 Mosher's ester of diol 24 indicated a 17:1 ratio of 2S,3R and 2R,3S enantiomers. Figures S1 and S2, Supporting Information). Difficulty in detecting CDP-EP and CDP-EEP is not surprising. CDP-MEP migrates at a poorly defined spot at the leading edge of that for ATP and only constitutes a maximum of ∼10% of the total radioactivity during time course measurements.
Negative-ion LC−MS analyses of incubation mixtures similar to those described in Figures 2 and 3 were performed using single ion monitoring, as previously described for MEP. 4, 5 They support the assignments for the products from incubations with EP or EEP. The reaction mixture from incubation of EP with CTP and IspDF gave a peak at m/z 506 and expected for CDP-E ( Figure 4A) . A similar analysis of the incubation of EP with CTP, ATP, IspDF, and IspE gave peaks m/z 263 for cEDP ( Figure 4B ) and m/z 322 for CMP (data not shown). Related incubations with EEP gave peaks at m/z 534 for CDP-EE ( Figure 4C ), m/z 291 for cEEDP (part D), and m/z 322 for CMP (data not shown).
In contrast to EP and EEP, MTP was not a substrate for IspD ( Figure 2 ). In addition, MTP at concentrations up to 5 mM did not inhibit turnover of MEP. Thus, it appears that the threitol diastereomer is not recognized by the active site of IspD.
Evaluation Figure S3 , Supporting Information, lanes 1 and 2). TLC analysis of a similar experiment with NMEP showed the formation of new radioactive materials with smaller R f 's than seen for the corresponding MEP derivatives that were not resolved into individual peaks ( Figure S3 , Supporting Information, lane 4). Related experiments with MEP where IspDF was replaced with H281S, a mutant which does not have IspF activity, gave spots for CDP-ME and CDP-MEP but not cMEDP, as expected ( Figure S3 Figure S3 , Supporting Information, lane 5) again gave unresolved spots at lower R f 's. The product mixtures were then analyzed by negative ion LC−MS. Selective ion monitoring at m/z 519 (CDP-NME), m/z 599 (CDP-NMEDP), and m/z 276 (cNMEDP) gave major peaks at 9.02 min (CDP-NME), 37.06 min (CDP-NMEDP), and 9.37 min (cNMEDP) ( Figures S4 and S5 , Supporting Information). Conclusions. Five MEP analogues were synthesized in this study. Four of these and their products were substrates for the three consecutive reactions catalyzed by IspDF and IspE. EP, EEP, NMEP, and MESP have topologies that are modestly different from that of MEP. In EP and EEP, a hydrogen atom and an ethyl group, respectively, replace the methyl group at C3 in MEP, and both analogues are converted to the corresponding cyclic diphosphates by ispDF and ispE. From a topological perspective, cEDP and its subsequent metabolites are likely alternate substrates for IspG and IspH. However, the resulting nor-analogues of IPP and DMAPP would be unreactive competitive inhibitors of IPP isomerase and farnesyl diphosphate (FPP) synthase, the next two enzymes in the isoprenoid pathway. 21, 22 In contrast, EEP would give ethyl analogues of IPP and DMAPP, which in turn are substrates for IPP isomerase and farnesyl diphosphate (FPP) synthase. 22 Related reactions are used to construct the carbon skeletons of insect juvenile hormones. 23 MTP, the threo diastereomer of MEP, is not a substrate for ispD and does not inhibit the enzyme. Conversion of cNMEDP to the amino analogue of HDMAPP by IspG would produce a potent nanomolar inhibitor of IspH. 24 cMESDP contains a highly conservative replacement of oxygen by sulfur that should not substantially impede its conversion to the thiolo analogue of DMAPP, at which point it becomes a low micromolar inhibitor of FPP synthase. 25 Thus, the ability of IspDF and IspE to process analogues of MEP presents an opportunity for in vivo synthesis of inhibitors of downstream enzymes and new metabolites.
■ EXPERIMENTAL SECTION
Mass analyzers used for HRMS were TOF (pure samples) or Quad/ TOF (HPLC/MS).
Synthesis of Alternate Substrates. 1,3-Benzylidene-D-erythritol, 4-(t-Butyldimethylsilyl) Ether (2) . A solution of dioxanone 1 (2.17 g, 6.73 mmol) 14 in MeOH (22 mL) was stirred and cooled at 0°C as NaBH 4 (305 mg, 8.08 mmol) was added portionwise over 10 min. The cooling bath was removed, and the reaction mixture was allowed to stir 1 h at rt. The reaction was neutralized by the addition of satd. NH 4 Cl (10 mL) and H 2 O (10 mL). The aqueous reaction mixture was extracted with CH 2 Cl 2 (2 × 100 mL). The organic extracts were combined, dried (MgSO 4 ), and evaporated to give 2.03 g of crude oil that was an 8:1 mixture ( 1 H NMR) of monosilyl ether 2 and starting material. Column purification (EtOAc:hexane 21:79) gave two fractions. After solvent was removed, the first contained 0.58 g of colorless oil that was a mixture of alcohol 2 (∼40%) and dioxanone 1 (∼40%), based on 1 H NMR analysis, and the second contained 1. 28 A solution of dibenzyl chlorophosphate was prepared by stirring a mixture of N-chlorosuccinimide (76 mg, 0.57 mmol) and dibenzyl phosphite (150 mg, 0.57 mmol) in benzene (2 mL) at room temperature for 1 h. The precipitate was separated by centrifugation and the supernatant added to a solution of 1,3-O-benzylidene-Derythritol 3 (100 mg, 0.48 mmol) in dry pyridine (4 mL) at 0°C. The resultant solution was stirred for 24 h at 0°C and 24 h at room temperature. Another portion of freshly prepared dibenzyl chlorophosphate (0.57 mmol) in benzene (1 mL) was added, and stirring was continued for 48 h. The reaction was quenched with ice (∼1 g), and volatiles were removed under reduced pressure. The residue was diluted with water (30 mL) and extracted with DCM (3 × 30 mL). The combined organic layers were dried over Na 2 SO 4 , and the solvent was evaporated. D-Erythritol 4-Phosphate, Ammonium Salt (EP). Deprotection of the dibenzyl phosphate (4, 24 mg, 0.05 mmol) was accomplished by hydrogenation using 20% Pd(OH) 2 /C (12 mg) in MeOH (3 mL) with magnetic stirring at 1 atm of H 2 for 24 h. The catalyst was filtered off, and the solvent was evaporated. The residue was dissolved in water (3 mL) followed by dropwise addition of 10% NH 4 OH (1 mL). 14 in dry ether (20 mL) was stirred and cooled at −78°C as EtMgBr (1.4 mL, 4.2 mmol, 3 M in Et 2 O) was added dropwise. After 45 min, the reaction was quenched with MeOH (5 mL) and allowed to warm to room temperature. Satd. aq. NH 4 Cl (15 mL) and water (15 mL) were added, and the product was extracted with ether (3 × 30 mL). The combined organic layers were washed with satd. 1,3-O-Benzylidene-2-C-ethyl-D-erythritol 4-Dibenzylphosphate (7). A solution of diol 6 (245 mg, 1.03 mmol) in THF (7 mL) was stirred and cooled at −78°C as an aliquot of 1.6 M BuLi in hexane (0.96 mL, 1.54 mmol) was added dropwise. After 5 min, a solution of dibenzyl chlorophosphate (1.54 mmol; freshly prepared from dibenzyl phosphite) in benzene (5 mL) prepared as described for 4 was added. Stirring was continued for 10 min at −78°C and 15 min at room temp. Ether (60 mL) and water (2 mL) were added, and the ethereal layer was dried (MgSO 4 ) and evaporated to give 520 mg of crude product. Purification by flash chromatography (silica gel, hexane/ethyl acetate 4:6) afforded 450 mg (88%) of an oil (14) 
2-C-Ethyl-D-erythritol 4-Phosphate, Ammonium Salt (EEP).
Compound 7 (410 mg, 0.82 mmol) was hydrogenated (1 atm, −10°C ) using 10% Pd/C (82 mg) in MeOH (10 mL) for 30 min. The mixture was filtered and solvent evaporated to give 270 mg of an oil. The oil was treated with 20% Pd(OH) 2 /C (130 mg) in MeOH (7 mL) at 1 atm of H 2 for 24 h. The catalyst was removed by filtration; solvent was evaporated; and the residue was purified by chromatography (silica gel, acetonitrile/isopropyl alcohol/10% aq. NH 4 . The temperature was allowed to rise to rt. After stirring for 3 h, the reaction was quenched with brine (15 mL). The layers were separated, and the aqueous layer was extracted with ether (3 × 10 mL). The combined organic extracts were dried over Na 2 SO 4 . The solvent was (12) . To a solution of phthalimide 11 (318 mg, 1 mmol) in EtOH (9 mL) was added hydrazine hydrate (150 mg, 3 mmol) in EtOH (1 mL). The solution was warmed to 50°C, stirred for 30 min, and heated at reflux for 2 h. The solution was cooled and filtered. The filter cake was washed with EtOH (3 × 10 mL), and solvent was removed at reduced pressure. The residue was dissolved in ether (20 mL), and 1 M NaOH (5 mL) was added to adjust the pH to 12. The aqueous layer was saturated with NaCl and extracted with ether. The combined organic extracts were dried over Na 2 SO 4 . The solvent was removed at reduced pressure to give 144 mg (77%) of a yellow liquid, which was used in the next step without further purification (14) . PPTS (25 mg, 0.1 mmol) was added to the solution of 13 (286 mg, 1 mmol) in EtOH (10 mL). The solution was stirred at 55°C for 1 h and allowed to cool to rt. The solvent was removed at reduced pressure, and the residue was chromatographed on silica with gradient elution by hexanes/ethyl acetate (0% to 40% ethyl acetate) to give 198 mg (98%) of a colorless oil: R f 0.56 (hexanes:ethyl acetate 1:1); 1 H NMR (CDCl 3 , 300 MHz) 1.43 (9H, s), 1.76 (3H, t, J = 0.7 Hz), 3.19 (1H, broad s), 3.74 (2H, dd, J 1 = 5.6 Hz, J 2 = 0.7 Hz), 4.14 (2H, t, J = 6.5 Hz), 4.91 (1H, broad s) (15) . A solution of I 2 (609 mg, 2.4 mmol) in CH 2 Cl 2 (30 mL) was added to a solution of P(OBn) 3 in CH 2 Cl 2 (20 mL) at −40°C. The mixture was stirred for 15 min, and the cooling bath was removed. After 30 min the solution became colorless and was cannulated to a mixture of alcohol 14 (200 mg, 1.2 mmol) and pyridine (570 mg, 7.2 mmol) in CH 2 Cl 2 (30 mL) at −40°C over 30 min. After the addition was complete, the mixture was stirred for 1 h at rt, and the solvents were removed at reduced pressure. The residue was dissolved in ether (50 mL) and washed with 0.3 M KHSO 4 (30 mL), satd. NaHCO 3 (30 mL), and brine (30 mL). The combined organic extracts were dried over Na 2 SO 4 , and solvent was removed at reduced pressure. The residue was chromatographed on silica gel with gradient elution by hexanes/ethyl acetate (0% to 30% ethyl acetate) to give 320 mg (70%) of a colorless oil: R f 0. 1-Deoxy-1-boc-amino-4-(dibenzyloxyphosphoryloxy)-3-methyl-D-erythritol (16) . A solution of AD mix β (3.14 g), NaHCO 3 (565 mg, 6.73 mmol), and CH 3 SO 2 NH 2 (160 mg, 1.68 mmol) in tBuOH:H 2 O (1:1 v/v, 12 mL) was cooled to 0°C, and alkene 15 (250 mg, 0.56 mmol) was added. The mixture was stirred overnight at 0°C before Na 2 SO 3 (3.36 g) was added. The temperature was allowed to rise to rt as the solution was stirred for 1 h. The layers were separated, and the aqueous layer was extracted with CH 2 Cl 2 (3 × 20 mL). The combined organic extracts were dried over Na 2 SO 4 , and solvent was removed at reduced pressure. The residue was chromatographed on silica with gradient elution by hexanes/ethyl acetate (0% to 30% ethyl acetate) to give 172 mg (64%) of a colorless oil: R f 0. (20) . A solution of 2 M LiBH 4 in THF (0.6 mL, 1.2 mmol) was added dropwise by a syringe to a solution of 19 (200 mg, 0.6 mmol) in ether (20 mL) at rt. The resulting solution was stirred for 1 h before EtOH (5 mL) and brine (5 mL) were added. The organic layer was separated, and the aqueous layer was extracted with ether (3 × 10 mL). The combined organic extracts were dried over Na 2 SO 4 . The solvent was removed at reduced pressure to give 175 mg (quant) of a colorless oil. This material partially decomposed when chromatographed on silica and was used in the next reaction without purification. A small sample was isolated by chromatography for characterization: R f 0.63 (hexanes:ethyl acetate 3:2); dr 87: 13 (2R,3S)-4-(tert-Butyldimethylsilanyloxy)-2,3-dihydroxy-3-methylbutyl Tosylate (22) . A solution of 21 (230 mg, 0.54 mmol) in THF (6 mL, 3 M HCl:THF, 1:25) was allowed to stir for 30 min. The mixture was cooled to 0°C; 6 mL of ammonia in MeOH were added; and the solution was allowed to stir for 15 min at rt. The solvent was removed at reduced pressure, and the residue was chromatographed on silica with gradient elution by hexanes/ethyl acetate (0% to 30% ethyl acetate) to give 160 mg (76%) of a colorless oil; R f 0. LC−MS Analysis. LC−MS analyses for incubations with EP, EEP, NMEP, and MESP similar to those described in the TLC analyses were carried out on a 1 mM scale using unlabeled CTP (0.75 mM), unlabeled ATP (0.75 mM), IspDF (4.8 μM), and IspE (6.2 μM). The reactions were incubated for 1 h and were centrifuged through a membrane (10 kDa cutoff) to remove the enzymes. Products were detected by negative-ion electrospray LC−MS using a Phenomex Prodigy 5 μ ODS(3) 100A (250 × 4.60 mm 5 μM) column eluted with 20 mM N,N′-dimethylhexylamine in 10% methanol, pH 7.0, adjusted with formic acid (Buffer A) and 2 mM N,N′-dimethylhexylamine in 50% methanol, pH 7.0 (Buffer B), as previously described. 
